Published online before print December 31, 2008
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||





,3
* Departments of Microbiology and
Pathology, Boston University School of Medicine, and
Department of Periodontology and Oral Biology, Boston University Goldman School of Dental Medicine, Boston, Massachusetts, USA; and
Department of Medicine, Section of Infectious Diseases, Evans Biomedical Research Center, Boston Medical Center, Boston, Massachusetts, USA
2 Correspondence: Boston University School of Medicine, Department of Microbiology, 72 E. Concord Street, L-516, Boston, MA 02118, USA. E-mail: bnikol{at}bu.edu
Chronic systemic inflammation links periodontal disease (PD) to increased incidence of cardiovascular disease. Activation of TLRs, particularly TLR4, promotes chronic inflammation in PD by stimulating myeloid cells. B cells from healthy individuals are generally refractory to TLR4 agonists as a result of low surface TLR4 expression. Unexpectedly, a significantly increased percentage of gingival and peripheral blood B cells from patients with PD expressed surface TLR4. Surface expression correlated with an active TLR4 promoter that mimicked the TLR4 promoter in neutrophils. B cells from PD patients were surface myeloid differentiation protein 2-positive and also packaged the enhancer of a proinflammatory cytokine, IL-1β, into an active structure, demonstrating that these cells harbor key characteristics of proinflammatory cell types. Furthermore, B cells lacked activating signatures of a natural IL-1β inhibitor, IL-1 receptor antagonist. Surprisingly, despite multiple signatures of proinflammatory cells, freshly isolated B cells from PD patients had decreased expression of TLR pathway genes compared with B cells from healthy individuals. Decreases in inflammatory gene expression were even more dramatic in B cells stimulated with a TLR4 ligand from a periodontal pathogen, Porphyromonas gingivalis LPS 1690. In contrast, B cell TLR4 was not activated by the prototypic TLR4 ligand Escherichia coli LPS. These findings raise the unexpected possibility that TLR4 engagement modulates B cell activation in PD patients.
Key Words: human bacterial infection inflammation gene regulation molecular biology
This article has been cited by other articles:
![]() |
M. Jagannathan, H. Hasturk, Y. Liang, H. Shin, J. T. Hetzel, A. Kantarci, D. Rubin, M. E. McDonnell, T. E. Van Dyke, L. M. Ganley-Leal, et al. TLR Cross-Talk Specifically Regulates Cytokine Production by B Cells from Chronic Inflammatory Disease Patients J. Immunol., December 1, 2009; 183(11): 7461 - 7470. [Abstract] [Full Text] [PDF] |
||||